A61B 5/4088
Diagnosing of monitoring cognitive diseases
Official title: {Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia}
A61B5/4088 (Diagnosing of monitoring cognitive diseases) appears on 909 US grants and 1,766 published applications in this corpus.
Search patents in A61B- Granted patents
- 909
- Published applications
- 1,766
- Assignees
- 853
- Inventors
- 3,258
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 3 |
| 2002 | 4 | 15 |
| 2003 | 3 | 10 |
| 2004 | 8 | 19 |
| 2005 | 2 | 17 |
| 2006 | 7 | 12 |
| 2007 | 4 | 9 |
| 2008 | 4 | 17 |
| 2009 | 4 | 25 |
| 2010 | 10 | 21 |
| 2011 | 12 | 24 |
| 2012 | 8 | 23 |
| 2013 | 14 | 31 |
| 2014 | 14 | 57 |
| 2015 | 34 | 77 |
| 2016 | 28 | 72 |
| 2017 | 31 | 99 |
| 2018 | 34 | 92 |
| 2019 | 58 | 119 |
| 2020 | 89 | 154 |
| 2021 | 68 | 149 |
| 2022 | 93 | 126 |
| 2023 | 87 | 158 |
| 2024 | 95 | 174 |
| 2025 | 112 | 165 |
| 2026 | 60 | 98 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Test device, method, and system for treating Alzheimer's disease6 Oct 2026US 12,752,127 B2
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Stratification method and stratification device15 Sep 2026US 12,733,854 B2Medical Research and Development Corporation
- Detection of cognitive impairment15 Sep 2026US 12,733,864 B2Accexible Impacto S.L.
- Information processing device, information processing method, information processing system and information processing program15 Sep 2026US 12,733,871 B2Pst Inc.
- Dementia assisting diagnosis system, dementia assisting diagnosis method and computer program product thereof8 Oct 2026US 2026/0306011 A1
- Early detection of neurocognitive decline using multi-modal mobile-device based assessment of personal photo interactions8 Oct 2026US 2026/0311886 A1Dabble Health, Inc.
- Systems and methods for evaluating the brain's response to spoken language1 Oct 2026US 2026/0294327 A1Cornell University
- Compositions and method for diagnosing and treating alzheimer's disease1 Oct 2026US 2026/0294328 A1The Regents of the University of California
- Hyperspectral Image-Guided Ocular Imager for Alzheimer's Disease Pathologies1 Oct 2026US 2026/0294329 A1Retispec Inc.
Most cited
By later US patents
- Closed-loop drug delivery system361US 7,108,680 B2Codman & Shurtleff, Inc. · 2006
- Use of brain electrophysiological quantitative data to classify and subtype an individual into diagnostic categories by discriminant and cluster analysis160US 5,083,571 ANew York University · 1992
- Standardized medical cognitive assessment tool144US 7,294,107 B2NeuroTrax Corporation · 2007
- Neurocognitive and psychomotor performance assessment and rehabilitation system136US 7,837,472 B1The United States of America as represented by the Secretary of the Army · 2010
- Method and apparatus for testing and training cognitive ability117US 6,632,174 B1Cognifit LTD (Naiot) · 2003